Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 119 Total
SEEL - Seelos Therapeutics Inc - Stock Price Chart
TickerSEEL [NASD]
CompanySeelos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.45MEPS (ttm)-8.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.30%
P/S2.02EPS next 5Y-
P/B-EPS Q/Q89.34%
Dividend-Sales Q/Q-
Insider Own8.70%Inst Own10.21%
Insider Trans12.34%Inst Trans-46.15%
Short Float6.87%Earnings-
Analyst Recom1.00Target Price4.00
Avg Volume429.50K52W Range0.27 - 49.80
Apr-29-24 08:00AM Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations (PR Newswire)
Mar-22-24 01:53PM SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Mar-19-24 08:43AM UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study (Reuters) -29.18%
08:23AM Seelos says ALS treatment fails in mid-stage study (Reuters)
08:15AM Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose) (PR Newswire)
Jan-26-24 08:30AM Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules (PR Newswire)
Jan-24-24 09:00AM How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition (PR Newswire) -10.74%
Jan-22-24 08:00AM Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002 (PR Newswire)
Jan-09-24 01:56PM Therapys New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution (InvestorPlace) +25.17%
Jan-02-24 08:00AM Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote 'FOR' All Proxy Proposals at the Special Meeting to be held on January 10, 2024 (PR Newswire)
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra RajSee RemarksDec 01 '23Buy1.3275,75799,999185,142Dec 01 04:16 PM
Golembiewski Michael JosephChief Financial OfficerNov 30 '23Buy1.2183,000100,22286,450Dec 01 04:16 PM
PLX - Protalix BioTherapeutics Inc. - Stock Price Chart
TickerPLX [AMEX, RUT]
CompanyProtalix BioTherapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap80.65MEPS (ttm)0.02
P/E48.89EPS this Y133.33%
Forward P/E1.36EPS next Y285.71%
PEG1.96EPS past 5Y-
P/S1.35EPS next 5Y25.00%
P/B2.70EPS Q/Q-15.41%
Dividend-Sales Q/Q-60.91%
Insider Own14.46%Inst Own13.25%
Insider Trans0.00%Inst Trans-5.54%
Short Float11.14%EarningsMay 10/b
Analyst Recom1.00Target Price13.00
Avg Volume395.99K52W Range1.07 - 3.10
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bashan DrorPRESIDENT AND CEOOct 19 '23Buy1.4064,51690,484132,516Oct 20 06:50 AM
HUGE - FSD Pharma Inc - Stock Price Chart
TickerHUGE [NASD]
CompanyFSD Pharma Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap13.75MEPS (ttm)-0.47
P/E-EPS this Y52.17%
Forward P/E-EPS next Y45.45%
PEG-EPS past 5Y31.10%
P/S-EPS next 5Y-
P/B1.01EPS Q/Q73.81%
Dividend-Sales Q/Q-
Insider Own16.97%Inst Own1.22%
Insider Trans0.00%Inst Trans-
Short Float1.11%EarningsMar 28/a
Analyst Recom1.00Target Price2.60
Avg Volume252.01K52W Range0.33 - 1.68
May-07-24 08:30AM FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia (ACCESSWIRE)
Apr-30-24 08:33AM FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication (ACCESSWIRE) -6.96%
Apr-25-24 07:47AM FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM) (ACCESSWIRE)
Apr-22-24 08:00AM FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) (ACCESSWIRE)
Apr-17-24 08:00AM FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products (ACCESSWIRE) -7.80%
Apr-15-24 08:00AM FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption (ACCESSWIRE) -12.40%
Apr-07-24 10:55PM FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (Newsfile)
Apr-01-24 10:00PM FSD Pharma Announces Filing of Year-End 2023 Results (ACCESSWIRE)
Mar-27-24 08:00AM FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults (ACCESSWIRE)
Mar-11-24 08:00AM FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) (ACCESSWIRE)
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
ENSC - Ensysce Biosciences Inc - Stock Price Chart
TickerENSC [NASD]
CompanyEnsysce Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap3.84MEPS (ttm)-7.76
P/E-EPS this Y35.50%
Forward P/E-EPS next Y22.81%
PEG-EPS past 5Y-
P/S1.75EPS next 5Y-
P/B0.34EPS Q/Q78.09%
Dividend-Sales Q/Q84.37%
Insider Own9.49%Inst Own1.10%
Insider Trans0.00%Inst Trans-3.96%
Short Float0.15%EarningsMar 15/b
Analyst Recom1.00Target Price12.25
Avg Volume183.59K52W Range0.53 - 4.23
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
TTEC - TTEC Holdings Inc - Stock Price Chart
TickerTTEC [NASD, RUT]
CompanyTTEC Holdings Inc
CountryUSA
IndustryInformation Technology Services
Market Cap345.76MEPS (ttm)-0.26
P/E-EPS this Y-35.19%
Forward P/E4.08EPS next Y26.10%
PEG-EPS past 5Y-25.46%
P/S0.14EPS next 5Y-
P/B0.58EPS Q/Q-112.35%
Dividend7.87%Sales Q/Q-9.13%
Insider Own59.19%Inst Own36.82%
Insider Trans0.00%Inst Trans-1.96%
Short Float17.30%EarningsMay 08/a
Analyst Recom2.43Target Price12.20
Avg Volume385.60K52W Range7.07 - 36.27
TTEC Holdings, Inc. is a digital global customer experience technology and services company. It focuses on the design, implementation, and delivery of transformative solutions for many brands. The firm operates through the following segments: TTEC Digital and TTEC Engage. The TTEC Digital segment provides design, build, and operate tech-enabled, insight-driven CX solutions. The TTEC Engage segment provides digitally-enabled customer care, acquisition, and fraud prevention services. The company was founded by Kenneth D. Tuchman in 1982 and is headquartered in Greenwood Village, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swanback Michelle RPRESIDENT, CEO, TTEC ENGAGEMay 02 '24Option Exercise0.0012,190028,703May 06 04:37 PM
Bourret FrancoisCHIEF ACCOUNTING OFFICERApr 14 '24Option Exercise0.001,19106,004Apr 16 04:44 PM
McLean Margaret BGC & CROApr 14 '24Option Exercise0.001,634054,757Apr 16 04:51 PM
Bourret FrancoisCHIEF ACCOUNTING OFFICERMar 17 '24Option Exercise0.002,71805,832Mar 19 04:35 PM
Swanback Michelle RPRESIDENT, CEO, TTEC ENGAGEMar 16 '24Option Exercise0.0010,986019,672Mar 19 04:31 PM
FTHM - Fathom Holdings Inc - Stock Price Chart
TickerFTHM [NASD]
CompanyFathom Holdings Inc
CountryUSA
IndustryReal Estate Services
Market Cap29.51MEPS (ttm)-1.42
P/E-EPS this Y60.52%
Forward P/E-EPS next Y85.00%
PEG-EPS past 5Y-64.63%
P/S0.09EPS next 5Y-
P/B0.57EPS Q/Q13.23%
Dividend-Sales Q/Q-9.08%
Insider Own39.57%Inst Own24.86%
Insider Trans-7.65%Inst Trans-11.61%
Short Float1.72%EarningsMay 09/a
Analyst Recom1.00Target Price4.50
Avg Volume61.14K52W Range1.36 - 8.20
Fathom Holdings, Inc. is a national, technology driven, end to end real estate services company, which engages in the provision of residential, brokerage, mortgage, title, insurance, and SaaS offerings for brokers and agents. It operates through the following segments: Real Estate Brokerage, Mortgage, Technology, and Corporate and Other Services. The company was founded by Joshua Harley in January 2010 and is headquartered in Cary, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murray Stephen H.DirectorDec 14 '23Buy2.6618,81750,05334,249Dec 18 04:10 PM
Flanders Scott NDirectorDec 05 '23Buy2.00300,000600,000446,100Dec 06 04:00 PM
Harley Joshua10% OwnerDec 05 '23Sale2.001,000,0002,000,0002,366,421Dec 05 04:15 PM
Venable Jennifer B.DirectorSep 13 '23Buy4.992,0009,97318,013Sep 15 06:28 PM
Harley JoshuaChief Executive OfficerSep 12 '23Sale5.033,38117,0203,366,421Sep 12 04:53 PM
GOCO - GoHealth Inc - Stock Price Chart
TickerGOCO [NASD, RUT]
CompanyGoHealth Inc
CountryUSA
IndustryInsurance Brokers
Market Cap89.56MEPS (ttm)-7.15
P/E-EPS this Y26.77%
Forward P/E-EPS next Y18.00%
PEG-EPS past 5Y-
P/S0.12EPS next 5Y-
P/B0.39EPS Q/Q7.38%
Dividend-Sales Q/Q1.33%
Insider Own21.73%Inst Own53.61%
Insider Trans0.35%Inst Trans-7.97%
Short Float2.76%EarningsMay 09/b
Analyst Recom1.67Target Price18.33
Avg Volume15.65K52W Range9.08 - 22.85
GoHealth, Inc. is a digital health company, which engages in the provision of insurance services. The firm's proprietary technology platform leverages machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs. The company was founded by Clint P. Jones and Brandon M. Cruz in 2001 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOTTE VIJAYChief Executive OfficerNov 13 '23Buy13.377,500100,275653,630Nov 15 10:10 AM
KOTTE VIJAYChief Executive OfficerMay 15 '23Buy13.787,24199,781646,130May 17 04:47 PM
Schulz JasonChief Financial OfficerMay 15 '23Buy14.296,88198,329273,548May 17 04:49 PM
LGMK - LogicMark Inc - Stock Price Chart
TickerLGMK [NASD]
CompanyLogicMark Inc
CountryUSA
IndustryHealth Information Services
Market Cap1.63MEPS (ttm)-11.77
P/E-EPS this Y66.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.58%
P/S0.16EPS next 5Y-
P/B0.12EPS Q/Q-32.82%
Dividend-Sales Q/Q13.01%
Insider Own11.94%Inst Own4.58%
Insider Trans0.00%Inst Trans-52.11%
Short Float0.23%EarningsApr 16/b
Analyst Recom-Target Price-
Avg Volume45.47K52W Range0.76 - 3.48
LogicMark, Inc. provides technology products and services for healthcare applications that enable the Internet of Things (IoT). It operates business in one segment-hardware and software security systems and applications. The firm develops and markets solutions for payment and IoT applications. Its technology products and solutions include MobileBio, a suite of biometric solutions that secure consumers' mobile platforms, the Wocket, a next-generation smart wallet and the Flye, a digital credit card developed in collaboration with WorldVentures. The company was founded by Gino Miguel Pereira and David Charles Tunnell on February 8, 2012 and is headquartered Louisville, KY.
TRVG - Trivago NV ADR - Stock Price Chart
TickerTRVG [NASD]
CompanyTrivago NV ADR
CountryGermany
IndustryInternet Content & Information
Market Cap47.54MEPS (ttm)-2.89
P/E-EPS this Y-135.65%
Forward P/E133.54EPS next Y129.52%
PEG-EPS past 5Y-48.14%
P/S0.09EPS next 5Y37.71%
P/B4.73EPS Q/Q-181.11%
Dividend-Sales Q/Q-7.59%
Insider Own0.83%Inst Own14.93%
Insider Trans0.00%Inst Trans0.70%
Short Float0.29%EarningsApr 30/a
Analyst Recom3.00Target Price2.73
Avg Volume66.66K52W Range2.20 - 3.50
trivago NV is a holding company, which engages in the provision of a global hotel and accommodation search platform. It also offers marketing tools and services for advertisers. It operates through the following segments: Americas, Developed Europe, Rest of World, and Corporate & Eliminations. The Americas segment consists of Argentina, Brazil, Canada, Chile, Columbia, Ecuador, Mexico, Peru, the United States, and Uruguay. The Developed Europe segment includes Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. The Rest of the World segment represents all other countries such as Australia, Japan, India, New Zealand, Russia, and Turkey. The Corporate and Eliminations segment refers to all corporate functions and expenses except for direct advertising. The company was founded by Rolf T.J. Schromgens, Peter Vinnemeier, and Stephan Stubner in 2005 and is headquartered in Dusseldorf, Germany.
COUR - Coursera Inc - Stock Price Chart
TickerCOUR [NYSE, RUT]
CompanyCoursera Inc
CountryUSA
IndustryEducation & Training Services
Market Cap1.38BEPS (ttm)-0.69
P/E-EPS this Y1747.94%
Forward P/E32.66EPS next Y46.29%
PEG-EPS past 5Y-21.68%
P/S2.10EPS next 5Y-
P/B2.28EPS Q/Q37.43%
Dividend-Sales Q/Q14.51%
Insider Own9.01%Inst Own69.03%
Insider Trans-13.87%Inst Trans-0.67%
Short Float5.58%EarningsApr 29/a
Analyst Recom1.67Target Price17.14
Avg Volume1.89M52W Range9.05 - 21.26
Coursera, Inc. is an online learning platform, which engages in the provision of online courses and degrees from universities and companies. It offers arts, chemistry, engineering, food, and nutrition, health, humanities, law, medicine, and music. The firm operates through the following segments: Consumer, Enterprise, and Degrees. The Consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers. The Enterprise segment consists of serving businesses, governmental organizations, and academic institutions by providing an intuitive online platform with access to job-relevant educational content enabling them to train, upskill, and reskill their employees, citizens, and students, faculty, and staff, respectively. The Degrees segment consists of partnering with universities to deliver fully online bachelor's and master's degrees. Coursera was founded by Daphne Koller and Andrew Y. Ng in 2011 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JACQUET RICHARD JSVP, Chief People OfficerMay 08 '24Sale9.4016,273152,903249,456May 10 06:10 PM
Maggioncalda Jeffrey NaceyPresident & CEOMay 02 '24Sale9.6050,000480,0102,127,496May 06 04:46 PM
Maggioncalda Jeffrey NaceyPresident & CEOApr 18 '24Sale11.9150,000595,5052,177,496Apr 22 05:26 PM
Meyers Michele MVP, Accounting, and CAOApr 18 '24Sale12.002,88034,560240,159Apr 22 05:23 PM
Ng Andrew Y.DirectorApr 17 '24Sale11.9525,000298,8407,033,074Apr 18 06:04 PM
123456789101112